Published in Pediatr Infect Dis J on March 01, 2006
Management of Kawasaki disease. Arch Dis Child (2013) 2.30
Epidemiology of Kawasaki disease in Asia, Europe, and the United States. J Epidemiol (2012) 1.70
Coronary artery lesions of incomplete Kawasaki disease: a nationwide survey in Japan. Eur J Pediatr (2011) 1.52
Natriuretic peptide as an adjunctive diagnostic test in the acute phase of Kawasaki disease. Pediatr Cardiol (2009) 1.46
Spatial and temporal clustering of Kawasaki syndrome cases. Pediatr Infect Dis J (2008) 1.05
Coronary artery outcomes among children with Kawasaki disease in the United States and Japan. Int J Cardiol (2013) 1.05
Risk factors for Kawasaki disease-associated coronary abnormalities differ depending on age. Eur J Pediatr (2009) 1.02
Coronary involvement in infants with Kawasaki disease treated with intravenous gamma-globulin. Pediatr Cardiol (2007) 1.01
Incomplete Kawasaki disease in patients younger than 1 year of age: a possible inherent risk factor. Eur J Pediatr (2008) 0.96
Epidemiology and risk factors for coronary artery abnormalities in children with complete and incomplete Kawasaki disease during a 10-year period. Pediatr Cardiol (2013) 0.96
Epidemiologic survey of Kawasaki disease in Jilin from 1999 through 2008. Pediatr Cardiol (2011) 0.94
Clinical manifestations vary with different age spectrums in infants with Kawasaki disease. ScientificWorldJournal (2012) 0.93
Epidemiologic features and prognostic factors of coronary artery lesions associated with Kawasaki disease based on a 13-year cohort of consecutive cases identified by complete enumeration surveys in Wakayama, Japan. J Epidemiol (2014) 0.89
Atipical Kawasaki disease with coronary aneurysm in infant. Ital J Pediatr (2011) 0.88
Prediction of resistance to standard intravenous immunoglobulin therapy in kawasaki disease. Korean Circ J (2014) 0.88
Profiles of responses of immunological factors to different subtypes of Kawasaki disease. BMC Musculoskelet Disord (2015) 0.81
Procalcitonin levels in patients with complete and incomplete Kawasaki disease. Dis Markers (2013) 0.80
Recurrent Kawasaki disease: USA and Japan. Pediatr Int (2015) 0.79
Kawasaki disease in infants. Korean J Pediatr (2013) 0.79
Rising hospitalization rates of Kawasaki Disease in Chile between 2001 and 2007. Rheumatol Int (2011) 0.79
Persistent fever in an infant: incomplete Kawasaki disease. CMAJ (2011) 0.78
Epidemiologic survey of Kawasaki disease in Inner Mongolia, China, between 2001 and 2013. Exp Ther Med (2016) 0.77
Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Eur J Pediatr (2012) 0.76
Cardiovascular status after Kawasaki disease in the UK. Heart (2015) 0.76
Ambient Air Pollutant Exposures and Hospitalization for Kawasaki Disease in Taiwan: A Case-Crossover Study (2000-2010). Environ Health Perspect (2016) 0.75
Can Coronary Artery Involvement in Kawasaki Disease be Predicted? Diagnostics (Basel) (2013) 0.75
Coronary artery thrombus resulting in sudden cardiac death in an infant with Kawasaki disease and giant coronary artery aneurysms. Ann Pediatr Cardiol (2013) 0.75
Novel Echocardiographic Indices for Assessing the Left Main Coronary Artery in Children With Kawasaki Disease. Iran J Pediatr (2016) 0.75
National survey of pediatric hospitalizations due to Kawasaki disease and coronary artery aneurysms in the USA. Clin Rheumatol (2016) 0.75
Trends in hospitalizations for pneumonia among persons aged 65 years or older in the United States, 1988-2002. JAMA (2005) 5.84
Norovirus and medically attended gastroenteritis in U.S. children. N Engl J Med (2013) 4.09
The relationship between in-home water service and the risk of respiratory tract, skin, and gastrointestinal tract infections among rural Alaska natives. Am J Public Health (2008) 3.09
A novel human disease with abnormal prion protein sensitive to protease. Ann Neurol (2008) 2.95
Myocardial injury and bacterial pneumonia contribute to the pathogenesis of fatal influenza B virus infection. J Infect Dis (2012) 2.48
Chronic wasting disease of elk: transmissibility to humans examined by transgenic mouse models. J Neurosci (2005) 2.46
Infant rotavirus vaccination may provide indirect protection to older children and adults in the United States. J Infect Dis (2011) 2.43
Rotavirus vaccine and health care utilization for diarrhea in U.S. children. N Engl J Med (2011) 2.41
Kawasaki syndrome hospitalizations in the United States, 1997 and 2000. Pediatrics (2003) 2.36
The roles of Clostridium difficile and norovirus among gastroenteritis-associated deaths in the United States, 1999-2007. Clin Infect Dis (2012) 2.34
Viral respiratory infections in hospitalized and community control children in Alaska. J Med Virol (2010) 2.29
Rickettsia parkeri rickettsiosis and its clinical distinction from Rocky Mountain spotted fever. Clin Infect Dis (2008) 2.27
Respiratory syncytial virus-associated hospitalizations among infants and young children in the United States, 1997-2006. Pediatr Infect Dis J (2012) 2.12
Lower respiratory tract infections among american Indian and Alaska Native children and the general population of U.S. Children. Pediatr Infect Dis J (2005) 2.07
Kawasaki syndrome and factors associated with coronary artery abnormalities in California. Pediatr Infect Dis J (2012) 2.03
Management of neurosurgical instruments and patients exposed to Creutzfeldt-Jakob disease. Infect Control Hosp Epidemiol (2013) 2.02
Iatrogenic Creutzfeldt-Jakob disease, final assessment. Emerg Infect Dis (2012) 2.01
First confirmed cases of Middle East respiratory syndrome coronavirus (MERS-CoV) infection in the United States, updated information on the epidemiology of MERS-CoV infection, and guidance for the public, clinicians, and public health authorities - May 2014. MMWR Morb Mortal Wkly Rep (2014) 2.00
Rocky mountain spotted fever in the United States, 2000-2007: interpreting contemporary increases in incidence. Am J Trop Med Hyg (2010) 1.99
Increasing rates of gastroenteritis hospital discharges in US adults and the contribution of norovirus, 1996-2007. Clin Infect Dis (2011) 1.98
Necrotising enterocolitis hospitalisations among neonates in the United States. Paediatr Perinat Epidemiol (2006) 1.97
Human coronavirus in young children hospitalized for acute respiratory illness and asymptomatic controls. Pediatr Infect Dis J (2012) 1.93
Burden of encephalitis-associated hospitalizations in the United States, 1988-1997. Clin Infect Dis (2002) 1.92
Parainfluenza virus infection of young children: estimates of the population-based burden of hospitalization. J Pediatr (2009) 1.90
Infectious disease hospitalizations among infants in the United States. Pediatrics (2008) 1.90
Chronic wasting disease and potential transmission to humans. Emerg Infect Dis (2004) 1.87
Long-term mortality in the United States cohort of pituitary-derived growth hormone recipients. J Pediatr (2004) 1.84
Respiratory syncytial virus hospitalizations among American Indian and Alaska Native infants and the general United States infant population. Pediatrics (2004) 1.83
Hospitalizations for Kawasaki syndrome among children in the United States, 1997-2007. Pediatr Infect Dis J (2010) 1.78
Skunk and raccoon rabies in the eastern United States: temporal and spatial analysis. Emerg Infect Dis (2003) 1.72
Clinical manifestations of human monkeypox influenced by route of infection. J Infect Dis (2006) 1.71
Epidemiology of human ehrlichiosis and anaplasmosis in the United States, 2001-2002. Am J Trop Med Hyg (2005) 1.69
Pathology and pathogenesis of fatal Bordetella pertussis infection in infants. Clin Infect Dis (2008) 1.68
Variably protease-sensitive prionopathy: a new sporadic disease of the prion protein. Ann Neurol (2010) 1.66
Direct and indirect effects of rotavirus vaccination upon childhood hospitalizations in 3 US Counties, 2006-2009. Clin Infect Dis (2011) 1.64
Diarrhea- and rotavirus-associated hospitalizations among children less than 5 years of age: United States, 1997 and 2000. Pediatrics (2006) 1.64
Uptake, impact, and effectiveness of rotavirus vaccination in the United States: review of the first 3 years of postlicensure data. Pediatr Infect Dis J (2011) 1.63
Kawasaki syndrome hospitalizations among children in the United States, 1988-1997. Pediatrics (2003) 1.62
Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States. Pediatrics (2008) 1.58
Protective association between rotavirus vaccination and childhood seizures in the year following vaccination in US children. Clin Infect Dis (2013) 1.49
Burden of encephalitis-associated hospitalizations in the United States, 1998-2010. Neurology (2014) 1.47
Infectious disease hospitalizations in the United States. Clin Infect Dis (2009) 1.43
Evaluation of potential infectivity of Alzheimer and Parkinson disease proteins in recipients of cadaver-derived human growth hormone. JAMA Neurol (2013) 1.42
Iatrogenic Creutzfeldt-Jakob disease in Australia: time to amend infection control measures for pituitary hormone recipients? Med J Aust (2010) 1.39
Secular variation in United States rotavirus disease rates and serotypes: implications for assessing the rotavirus vaccination program. Pediatr Infect Dis J (2009) 1.36
Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002. Pediatr Infect Dis J (2006) 1.35
Risk factors for bronchiolitis-associated deaths among infants in the United States. Pediatr Infect Dis J (2003) 1.35
Burden of norovirus gastroenteritis in the ambulatory setting--United States, 2001-2009. J Infect Dis (2013) 1.34
The public health impact of prion diseases. Annu Rev Public Health (2005) 1.33
Seasonal trends of human parainfluenza viral infections: United States, 1990-2004. Clin Infect Dis (2006) 1.30
Effectiveness of pentavalent rotavirus vaccine against severe disease. Pediatrics (2011) 1.26
Kawasaki syndrome in Denmark. Pediatr Infect Dis J (2007) 1.24
Kawasaki syndrome in Hawaii. Pediatr Infect Dis J (2005) 1.24
Effectiveness of pentavalent and monovalent rotavirus vaccines in concurrent use among US children <5 years of age, 2009-2011. Clin Infect Dis (2013) 1.23
Infectious disease hospitalizations among American Indian and Alaska native infants. Pediatrics (2003) 1.23
Evaluation of smallpox vaccines using variola neutralization. J Gen Virol (2009) 1.21
Monitoring the occurrence of emerging forms of Creutzfeldt-Jakob disease in the United States. Neurology (2003) 1.19
Infection control practices and zoonotic disease risks among veterinarians in the United States. J Am Vet Med Assoc (2008) 1.18
Racial/ethnic differences in the incidence of Kawasaki syndrome among children in Hawaii. Hawaii Med J (2010) 1.17
Disease burden and risk factors for hospitalizations associated with rotavirus infection among children in New York State, 1989 through 2000. Pediatr Infect Dis J (2003) 1.15
Infectious disease hospitalizations among older adults in the United States from 1990 through 2002. Arch Intern Med (2005) 1.15
Viral meningitis-associated hospitalizations in the United States, 1988-1999. Neuroepidemiology (2003) 1.13
All-cause gastroenteritis and rotavirus-coded hospitalizations among US children, 2000-2009. Clin Infect Dis (2012) 1.12
National surveillance and the epidemiology of human Q fever in the United States, 1978-2004. Am J Trop Med Hyg (2006) 1.12
Trends in lower respiratory tract infection hospitalizations among American Indian/Alaska Native children and the general US child population. J Pediatr (2012) 1.12
Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis (2008) 1.12
Disparities in infectious disease hospitalizations for American Indian/ Alaska Native people. Public Health Rep (2011) 1.10
Analysis of potential risk factors associated with nonresponse to initial intravenous immunoglobulin treatment among Kawasaki disease patients in Japan. Pediatr Infect Dis J (2008) 1.09
Infant and maternal risk factors for pertussis-related infant mortality in the United States, 1999 to 2004. Pediatr Infect Dis J (2009) 1.08
Amyotrophic lateral sclerosis mortality in the United States, 1979-2001. Neuroepidemiology (2005) 1.08
Use of respiratory syncytial virus surveillance data to optimize the timing of immunoprophylaxis. Pediatrics (2010) 1.08
Rocky Mountain spotted fever in the United States, 1997-2002. Vector Borne Zoonotic Dis (2006) 1.08
Outbreak of pneumonia associated with emergent human adenovirus serotype 14--Southeast Alaska, 2008. J Infect Dis (2010) 1.08
Knowledge of bat rabies and human exposure among United States cavers. Emerg Infect Dis (2002) 1.07
Methicillin-resistant Staphylococcus aureus-associated hospitalizations among the American Indian and Alaska native population. Clin Infect Dis (2009) 1.07
Re: Examining the Association Between Kawasaki Disease and Pertussis. Epidemiology (2015) 1.07